Healthtech takes off with $2.2B in nearly 70 deals

Some of the big deals that have taken place this year include:

• Flatiron Health, a company that organizes real-time oncology data to help cancer patients and doctors, which raised $130 million in Series B funding from Google Ventures, First Round Capital, Laboratory Corporation of America, and angel investors

• Healthcare data warehousing and analytics company Health Catalyst, which raised $41 million in funding from Sequoia Capital, Norwest Venture Partners,  Kaiser Permanente Ventures, Sorenson Capital, CHV Capital and Partners HealthCare

• Telcare, a connected devices platform for diabetes management, which raised $32.5 million in a Series C round of funding led by Norwest Venture Partners with participation from Mosaic Health Solutions, Sequoia and Qualcomm.

When broken down by stage, its not surprising, given the relative age of this sector, that the vast majority of deals have been in the early to mid stages.

More than three quarters, 76%, of all healthtech deals this year were Series C or below. Only 16% were Series D, including raises by Practice Fusion, Voluntis and HealthSense.

The report also broke deals down by state. Do I have to tell you that California led the way with 36% of the deals? No? Ok.

Next, way down the list were Massachusetts and New York with 9%, followed by Ohio with 6%, and Minnesota and Virginia with 4%. 

And, finally, the top five firms currently investing in the healthtech sector are Qualcomm Ventures, Merck Global Health Innovation Fund, BlueCross BlueShield Venture Partners, Google Ventures and Intel Capital.

(Image source: futurama.wikia.com)